Şunu aradınız:: proteinuria (Maltaca - İngilizce)

proteinuria, uġigħ renali
proteinuria, renal pain

proteinuria, uġigħ renali rari
proteinuria, renal pain

ux proteinuria, uġigħ renali rari
proteinuria, renal pain

proteinuria, uġigħ renali rari li l
proteinuria, renal pain

ematurja, proteinuria disturbi ġenerali u kundizzjonijiet ta ’ mnejn jingħata
haematuria, proteinuria general disorders and administration site conditions

ematurja/ proteinuria seħħet f’ numru żgħir ta ’ pazjenti.
24 haematuria/ proteinuria occurred in a small number of patients.

proteinuria*, żieda fil-kreatinina fid-demm, insuffiċjenza tal-kliewi
proteinuria*, blood creatinine increased, renal failure*

ematurja kienet komuni u proteinuria seħħet f’numru żgħir ta’ pazjenti.
haematuria was common and proteinuria occurred in a small number of patients.

il- kejl ewlieni tal-effikaċja kien il-ħila tal-mediċina li tnaqqas il-proteinuria.
the main measure of effectiveness was the ability to reduce proteinuria.

semintra kien effikaċi daqs il-benażepril fit-tnaqqis tal-proteinuria fi qtates b’mard renali kroniku.
semintra was as effective as benazepril in reducing proteinuria in cats with chronic kidney disease.

id-dewmien fil-progressjoni għal proteinuria klinika kien evidenti kmieni sa minn tlett xhur u baqa' għal iktar minn perjodu ta' 2 snin.
the slowing in the progression to clinical proteinuria was evident as early as three months and continued over the 2 year period.

l-istudju ta' "l-effetti ta' irbesartan fuq il-mikroalbuminuria fil-pazjenti bi pressjoni għolja b'tip 2 ta' diabete mellitus (irma)" juri li irbesartan 300 mg jittardja il-progressjoni għal proteinuria li tidher f'pazjenti b'mikroalbuminuria.
the study of the “effects of irbesartan on microalbuminuria in hypertensive patients with type 2 diabetes mellitus (irma 2)” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria.